Delivery Order SPE2DB20D3103-SPE2DB24FM8S1
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Verapamil 5 mg/2 ml vials. The potential value of the contract is $1,494.93, with a completion date of February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- This federal contract award is for the delivery of 4,565,419,208 units of the pharmaceutical product Verapamil 10 mg/4 ml vial. The fixed-price delivery order, valued at $1,564.95, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment programs and healthcare...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,596.20, is for the delivery of verapamil 5 mg/2 ml vials. The contract has a completion date of February 19, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Verapamil 5 mg/2 ml vials. The contract, valued at $1,772.86, is a firm fixed-price delivery order with a completion date of January 4, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of verapamil 5 mg/2 ml vials. The firm-fixed-price delivery order, valued at $4,384.79, has a completion date of July 17, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Verapamil 120 mg tablets. The $1,556.08 firm fixed-price contract has a completion date of June 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
- This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8SL7, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of Verapamil 5 mg/2 ml vials, with a total ceiling value of $2,321.94. It is a firm fixed-price delivery order contract with an ultimate completion date of August 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this...
- The Defense Logistics Agency awarded a delivery order valued at $7,687.44 to AmerisourceBergen Drug Corp for the supply of Verapamil 5 mg/2 mL vials on January 5, 2026, with completion targeted for January 6, 2026. This firm fixed price delivery order was awarded without a set-aside designation through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Verapamil 5 mg/2 ml ampules, a cardiovascular medication, with a ceiling value of $1,810.22 and a completion date of May 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,339.92 firm fixed-price delivery order is for the supply of 4564858692 - VERAPAMIL 5 MG/2 ML VIAL 2ML, a cardiovascular medication. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM8S1Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Verapamil 5 mg/2 ml vials. The award has a completion date of March 1, 2024 and a potential value of $3,724.25. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 2/29/24 |